Autonomix Medical - AMIX Company Value to Revenue Ratio

Autonomix Medical, Inc. (AMIX) develops high-precision neuromodulation systems to combat neurological pathologies. The company's enterprise value-to-revenue trend on the GURU.Markets chart demonstrates the market valuation of assets, where the metric settled at 0.00. Business growth is driven by the expansion of catheter sensors in clinics and the strengthening of the commercial team with experienced sales managers specializing in specialized equipment.
AMIX (autonomix.com): analytical breakdowns and indicator data

To minimize fundamental risks, investors should select assets with a moderate Enterprise Value-to-Sales ratio, excluding the impact of leverage. This metric determines the market valuation of operational activities, and the EV/Sales history allows for an assessment of the value of Autonomix Medical, Inc. (AMIX) innovative chronic pain management systems relative to their generated cash flow.